Cargando…
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future
OBJECTIVE: This review summarizes the current status of neoadjuvant therapy and discusses the choice of new clinical research endpoints for non-small cell lung cancer. BACKGROUND: Neoadjuvant chemotherapy is a recognized practice in patients with resectable and locally advanced lung cancer. With the...
Autores principales: | Ren, Sijia, Xu, Anyi, Lin, Yilian, Camidge, D. Ross, Di Maio, Massimo, Califano, Raffaele, Hida, Toyoaki, Rossi, Antonio, Guibert, Nicolas, Zhu, Chengchu, Shen, Jianfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350086/ https://www.ncbi.nlm.nih.gov/pubmed/34430363 http://dx.doi.org/10.21037/tlcr-21-259 |
Ejemplares similares
-
Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020) -
Past, present and future of hemophilia: a narrative review
por: Franchini, Massimo, et al.
Publicado: (2012) -
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2020) -
Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook
por: Jin, Zixian, et al.
Publicado: (2021) -
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)